Exploring the effects of light and electrical stimulation on sleep disorders
The Impact of Light, Electrical, and Magnetic Neuroregulation Interventions on Sleep-wake Disorders
This study is testing if light therapy and brain stimulation can help people with sleep disorders like insomnia and narcolepsy get better sleep.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 8 Years to 75 Years |
| Sex | All |
| Sponsor | Second Affiliated Hospital of Soochow University Academic / other |
| Locations | 1 site (Suzhou, Jiangsu) |
| Trial ID | NCT06797284 on ClinicalTrials.gov |
What this trial studies
This study investigates the use of neuromodulation techniques, including phototherapy and transcranial magnetic stimulation, to treat sleep-wake disorders such as insomnia, narcolepsy, and REM sleep behavior disorder. Participants will undergo self-controlled interventions to assess the effectiveness of these therapies in improving sleep quality and regulating sleep patterns. The study aims to develop new technologies and approaches for managing these conditions through precise neuromodulation.
Who should consider this trial
Good fit: Ideal candidates include individuals diagnosed with insomnia, narcolepsy, or REM sleep behavior disorder by a specialist.
Not a fit: Patients with major neurological diseases, severe psychiatric disorders, or significant systemic illnesses may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide new, effective treatment options for patients suffering from chronic sleep disorders.
How similar studies have performed: While neuromodulation approaches have been explored in other studies, this specific combination of interventions is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Patients with insomnia, narcolepsy,and RBD that have been clearly diagnosed by specialists should sign the informed consent form. Exclusion Criteria: 1. Patients with major neurological diseases such as multi-infarct dementia, Huntington\'s disease, normal pressure hydrocephalus, brain tumors, progressive supranuclear palsy, epilepsy, subdural hematoma, multiple sclerosis, or those who have sustained neurological dysfunction or known structural brain abnormalities after significant head trauma are excluded. 2. A history of major depressive disorder or bipolar disorder within the past year, as defined in DSM-IV criteria. A history of schizophrenia (meeting DSM-IV criteria). 3. History of severe drug or alcohol abuse within the past year; 4. Any significant systemic illness or unstable medical condition that may make it difficult to comply with the protocol, such as severe autoimmune diseases or a history of cancer. 5. Have significant hearing, visual, or cognitive impairments, or are unable to participate in interviews in a meaningful way.
Where this trial is running
Suzhou, Jiangsu
- Department of Neurology, Second Affiliated Hospital of Soochow University — Suzhou, Jiangsu, China (Recruiting)
Study contacts
- Study coordinator: Chun-Feng Liu, PhD
- Email: liuchunfeng@suda.edu.cn
- Phone: +86 512 67783307
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.